TY  - JOUR 
AU  - Paez-Vega, A
AU  - Cantisan, S
AU  - Vaquero, JM
AU  - Vidal, E
AU  - Luque-Pineda, A
AU  - Lobo-Acosta, MA
AU  - Pérez, AB
AU  - Alonso-Moralejo, R
AU  - Iturbe, D
AU  - Monforte, V
AU  - Otero González, Isabel
AU  - Pastor, A
AU  - Ussetti, P
AU  - Torre-Cisneros, J
PY  - 2019
UR  - http://hdl.handle.net/20.500.11940/12323
AB  - INTRODUCTION:
Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The...
LA  - eng
KW  - Lung Transplantation
TI  - Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.
T2  - BMJ Open
M2  - e030648
KW  - Trasplante de pulmón
VL  - 9
ER  -